Secreted factors

• US 6,800,455 B2
• Filed: 03/14/2001
• Issued: 10/05/2004
• Est. Priority Date: 03/31/2000
• Status: Expired due to Term

• Current Assignee: Scios, Inc. (Johnson & Johnson)
• Original Assignee: Scios, Inc. (Johnson & Johnson)
• Inventors: Stanton, Lawrence W., White, R. Tyler
• Primary Examiner(s): Martinell, James
• Application Number:
  US09/809,545
• Publication Number:
  US 20020110804A1
• Time in Patent Office: 1,301 Days
• Field of Search: 536/23.1, 536/23.5, 536/24.3, 536/24.31, 435/320.1, 435/252.3, 435/325, 435/69.1, 435/6
• US Class Current: 435/69.1
• CPC Class Codes: A61P 13/12 of the kidneys
• CPC Class Codes: A61P 9/00 Drugs for disorders of the cardiovascular system
• CPC Class Codes: C07K 14/47 from mammals

Abstract

The invention concerns new secreted factors encoded by clones P00184_D11 (SEQ ID NO:1), P00185_D11 (SEQ ID NO:3), P00188_D12 (SEQ ID NO:5), P00188_E01 (SEQ ID NO:7), P00194_G01 (SEQ ID NO:9), P00194_G05 (SEQ ID NO:11), P00194_H10 (SEQ ID NO:13), P00199_D08 (SEQ ID NO:15), P00203_D04 (SEQ ID NO:17), P00203_E06 (SEQ ID NO:19), P00209_F06 (SEQ ID NO:21), P00219_D02 (SEQ ID NO:23), P00219_F06 (SEQ ID NO:25), P00220_H05 (SEQ ID NO:27), P00222_G03 (SEQ ID NO:29), P00225_C01 (SEQ ID NO:32), P00227_D11 (SEQ ID NO:34), P00228_F03 (SEQ ID NO:36), P00233_H08 (SEQ ID NO:38), P00235_G08 (SEQ ID NO:40), P00239_C11 (SEQ ID NO:42), P00240_E05 (SEQ ID NO:45), P00247_A04 (SEQ ID NO:50), P00248_B04 (SEQ ID NO:52), P00249_F09 (SEQ ID NO:54), P00258_A10 (SEQ ID NO:56), P00262_C10 (SEQ ID NO:58), P00269_H08 (SEQ ID NO:62), P00628_H02 (SEQ ID NO:66), P00629_C08 (SEQ ID NO:68), P00641_G11 (SEQ ID NO:71), P00648_E12 (SEQ ID NO:73), P00697_C03 (SEQ ID NO:75), and other mammalian homologues and variants of such factor, as well as polynucleotides encoding them. The invention further concerns methods and means for producing such factors and their use in the diagnosis and treatment of various cardiac, renal or inflammatory diseases.

Claims

1. An isolated nucleic acid molecule comprising a poly- or oligonucleotide selected from the group consisting of:

(a) a polynucleotide encoding at least 50 contiguous amino acids from amino acids 1 to 148 of SEQ ID NO;

2;

(b) a polynucleotide encoding a polypeptide having at least 75% sequence identity with amino acids 1 to 203 of SEQ ID NO;

2 and

(c) a polynucleotide of SEQ ID NO;

1.

2. A vector comprising and capable of expressing the poly- or oligonucleotide of claim 1.

3. A recombinant host cell transformed with nucleic acid comprising the poly- or oligonucleotide of claim 1.

4. A recombinant host cell transformed with the vector of claim 2.

5. A method for producing a polypeptide comprising culturing a recombinant host cell transformed with nucleic acid comprising any of the polynucleotides of claim 1(a)-(c) under conditions such that the polypeptide is expressed, and isolating the polypeptide.